Fax: 713-794-4662
1097-0142/asset/olbannerleft.gif?v=1&s=ca681f5719430b26e1bc15e9ea4c9fc0a7110104)
1097-0142/asset/olbannerright.gif?v=1&s=8142566facf7e76aef9be6c51162a2e920b3b9f9)
Original Article
You have full text access to this OnlineOpen article
Family history of cancer and risk of sporadic differentiated thyroid carcinoma†
Article first published online: 28 JUL 2011
DOI: 10.1002/cncr.26398
Copyright © 2011 American Cancer Society
Additional Information
How to Cite
Xu, L., Li, G., Wei, Q., El-Naggar, A. K. and Sturgis, E. M. (2012), Family history of cancer and risk of sporadic differentiated thyroid carcinoma. Cancer, 118: 1228–1235. doi: 10.1002/cncr.26398
- †
We thank Margaret Lung, Kathyrn Patterson, Liliana Mugartegui, and Jenny Vo for their help with subject recruitment and Stephanie Deming for manuscript editing.
- ‡
Fax: 713-794-4662
Publication History
- Issue published online: 17 FEB 2012
- Article first published online: 28 JUL 2011
- Manuscript Accepted: 6 JUN 2011
- Manuscript Revised: 2 MAY 2011
- Manuscript Received: 23 FEB 2011
REFERENCES
- 1, , , et al. Cancer statistics, 2010. CA Cancer J Clin. 2010; 60: 277-300.
- 2Altekruse SF, Kosary C, Krapcho M, et al, eds. SEER Cancer Statistics Review 1975-2007. Bethesda, MD: National Cancer Institute; 2010.
- 3, . Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA. 2006; 295: 2164-2167.
- 4, . Improved detection does not fully explain the rising incidence of well-differentiated thyroid cancer: a population-based analysis. Am J Surg. 2010; 200: 454-461.
- 5, , . Increasing incidence of differentiated thyroid cancer in the United States, 1988-2005. Cancer. 2009; 115: 3801-3807.
- 6, , , et al. Recent advances in thyroid cancer. Curr Probl Surg. 2008; 45: 156-250.
- 7, . Familial thyroid cancer. Curr Opin Oncol. 2001; 13: 44-51.
- 8, . Risk factors for thyroid cancer. Trends Endocrinol Metab. 1997; 8: 20-25.
- 9, , , et al. Iodine and thyroid cancer risk among women in a multiethnic population: the Bay Area Thyroid Cancer Study. Cancer Epidemiol Biomarkers Prev. 2001; 10: 979-985.
- 10, , , et al. A population-based case-control study of thyroid cancer. J Natl Cancer Inst. 1987; 79: 1-12.
- 11, , , et al. Parental cancer and risk of papillary and follicular thyroid carcinoma. Br J Cancer. 1997; 75: 451-456.
- 12, , , et al. Malignant tumors in families of thyroid cancer patients. Acta Oncol. 1997; 36: 477-481.
- 13, , , et al. Lifestyle and other risk factors for thyroid cancer in Los Angeles County females. Ann Epidemiol. 2002; 12: 395-401.
- 14, , , et al. Increased risk for nonmedullary thyroid cancer in the first degree relatives of prevalent cases of nonmedullary thyroid cancer: a hospital-based study. J Clin Endocrinol Metab. 2001; 86: 5307-5312.
- 15, , , et al. Family history of thyroid cancer and the risk of differentiated thyroid cancer in French Polynesia. Thyroid. 2010; 20: 393-400.
- 16, , , et al. Family history of benign thyroid disease and cancer and risk of thyroid cancer. Eur J Cancer. 2004; 40: 754-760.
- 17, , . Familial occurrence of nonmedullary thyroid cancer: a population-based study of 5673 first-degree relatives of thyroid cancer patients from Norway. Cancer Epidemiol Biomarkers Prev. 2001; 10: 113-117.
- 18, , , et al. Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. J Natl Cancer Inst. 1994; 86: 1600-1608.
- 19, . Familial relationships in thyroid cancer by histo-pathological type. Int J Cancer. 2000; 85: 201-205.
- 20, , , et al. Familial nonmedullary thyroid cancer. An emerging entity that warrants aggressive treatment. Arch Surg. 1995; 130: 892-897.
- 21, . The impact of confounder selection criteria on effect estimation. Am J Epidemiol. 1989; 129: 125-137.
- 22, , . Familial risks for nonmedullary thyroid cancer. J Clin Endocrinol Metab. 2005; 90: 5747-5753.
- 23, , , et al. The basis of racial differences in the incidence of thyroid cancer. Ann Surg Oncol. 2008; 15: 1169-1176.
- 24, , , et al. A pooled analysis of case-control studies of thyroid cancer. II. Menstrual and reproductive factors. Cancer Causes Control. 1999; 10: 143-155.
- 25, , , et al. Influence of cigarette smoking on goiter formation, thyroglobulin and thyroid hormone levels in women. J Clin Endocrinol Metab. 1984; 58: 615-618.
- 26, , , et al. Cigarette smoking and thyroid hormone levels in males. Int J Epidemiol. 1997; 26: 972-977.
- 27, , , et al. RET polymorphisms and haplotypes and risk of differentiated thyroid cancer. Laryngoscope. 2005; 115: 1035-1041.
- 28, , , et al. Association of XRCC1 polymorphisms and risk of differentiated thyroid carcinoma: a case-control analysis. Thyroid. 2009; 9: 129-135.
- 29, , , et al. Radiation response genotype and risk of differentiated thyroid cancer: a case-control analysis. Laryngoscope. 2005; 115: 938-945.
- 30, , , et al. Glutathione S-transferase polymorphisms and risk of differentiated thyroid carcinomas: a case-control analysis. Arch Otolaryngol Head Neck Surg. 2006; 132: 756-761.
- 31, , , et al. Thyroid cancer after exposure to external radiation: a pooled analysis of 7 studies. Radiat Res. 1995; 141: 259-277.
- 32, , , et al. Multiple thyroid involvement (intraglandular metastasis) in papillary thyroid carcinoma. A clinicopathologic study of 105 consecutive patients. Cancer. 1992; 70: 1585-1590.
- 33, , , et al. Multifocality in well-differentiated thyroid carcinomas calls for total thyroidectomy. Am J Surg. 2011; 201: 770-775.
- 34, , , et al. Independent clonal origins of distinct tumor foci in multifocal papillary thyroid carcinoma. N Engl J Med. 2005; 352: 2406-2412.
- 35, , , et al. Papillary thyroid carcinoma: the impact of therapy in 576 patients. Medicine (Baltimore). 1977; 56: 171-196.
- 36, , , et al. Accuracy of reporting of family history of colorectal cancer. Gut. 2004; 53: 291-295.
- 37, , , et al. Accuracy of family history of cancer obtained through interviews with relatives of patients with childhood sarcoma. J Clin Epidemiol. 1994; 47: 89-96.
- 38, , . Does this patient have a family history of cancer? An evidence-based analysis of the accuracy of family cancer history. JAMA. 2004; 292: 1480-1489.